Search Results 331-340 of 16654 for pharmacogenetics
Review the student roster and career outcomes of the Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
About this study. The primary objective of CONVERGE PAS is to evaluate clinical outcomes (peri-procedural and long-term) in a cohort of patients treated ...
The Lucas-McAllister Oncoimmune Signaling and Therapeutics Laboratory at Mayo Clinic is researching lymphoma, breast cancer, brain cancer and liver cancer.
This is a study of AMT-260 in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy (MTLE). It is designed to investigate the Safety, Tolerability, ...
About this study. The purpose of this study is to establish at least 200 patient-derived cancer xenografts (PDXs), and to utilize these PDXs in preclinical ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
See educational opportunities and alumni in Nilufer Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes lab at Mayo Clinic.
... . IMG-20448211. Home; find-cure-appignanis-12col. 3X your impact! Give Now! Your gift can go 3X as far to shape the future of cancer care.
ROCHESTER, Minn. — Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer.[.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.